Estimation of liver T*2 in transfusion-related iron overload in patients with weighted least squares T*2 IDEAL

Magnetic Resonance in Medicine

Volumn 67, Issue 1, 2012, Pages 183-190

  Vasanawala, Shreyas S ^a   Yu, Huanzhou ^b   Shimakawa, Ann ^b   Jeng, Michael ^a   Brittain, Jean H ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

hemosiderosis; iron overload

Indexed keywords

IRON; MAGNETIC RESONANCE IMAGING;

DECOMPOSITION OF WATERS; GRADIENT ECHO SEQUENCES; HEMOSIDEROSIS; IRON OVERLOADS; LEAST SQUARES ESTIMATION; VOLUMETRIC ESTIMATION; WEIGHTED LEAST SQUARES; WEIGHTED-LEAST-SQUARES ALGORITHM;

ITERATIVE METHODS;

ADOLESCENT; ADULT; ANEMIA; APLASTIC ANEMIA; ARTICLE; BETA THALASSEMIA; BLACKFAN DIAMOND ANEMIA; CHILD; CLINICAL ARTICLE; ERYTHROCYTE APLASIA; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMAGE PROCESSING; INFANT; IRON OVERLOAD; LEUKEMIA; LIVER; LYMPHOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; SCHOOL CHILD; SICKLE CELL ANEMIA; SIGNAL NOISE RATIO; SIMULATION; TRANSFUSION;

EID: 84255178974     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22986     Document Type: Article

References (32)

1. Taher A, Al Jefri A, Elalfy MS, Al Zir K, Daar S, Rofail D, Baladi JF, Habr D, Kriemler-Krahn U, El-Beshlawy A,. Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-Thalassemia: results from the ESCALATOR Trial. Acta Haematol 2010;123: 220-225.
2. Taher A, El-Beshlawy A, Elalfy MS, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Hmissi A, Al Jefri A,. Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study. Eur J Haematol 2009; 82: 458-465.
3. Kontoghiorghes GJ,. Introduction of higher doses of deferasirox: better efficacy but not effective iron removal from the heart and increased risks of serious toxicities. Expert Opin Drug Saf 2010;9: 633-641.
4. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ,. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18: 33-39. (Pubitemid 36791266)
5. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ,. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006; 91: 1388-1391. (Pubitemid 44569814)
6. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y,. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362. (Pubitemid 38169542)
7. Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia-Bengoechea M, Barrio J, Mujica F, Recondo JA,. MR quantification of hepatic iron concentration. Radiology 2004; 230: 479-484. (Pubitemid 38133810)
8. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ,. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179. (Pubitemid 33139463)
9. Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Hermine C,. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997; 168: 1205-1208. (Pubitemid 27183793)
10. Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhe T, Brissot P, Carsin M, Deugnier Y,. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994; 193: 533-538.
11. Gotsis ED,. The uses and differences of r2 and r2* in the determination of iron overload in iron loaded thalassemia patients. Hemoglobin 2008; 32: 75-83. (Pubitemid 351264518)
12. Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W,. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990; 74: 360-363. (Pubitemid 20106066)
13. Papakonstantinou O, Alexopoulou E, Economopoulos N, Benekos O, Kattamis A, Kostaridou S, Ladis V, Efstathopoulos E, Gouliamos A, Kelekis NL,. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major. J Magn Reson Imaging 2009; 29: 853-859.
14. Papakonstantinou OG, Maris TG, Kostaridou V, Gouliamos AD, Koutoulas GK, Kalovidouris AE, Papavassiliou GB, Kordas G, Kattamis C, Vlahos LJ, Papavassiliou CG,. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 1995; 13: 967-977.
15. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R,. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105: 855-861. (Pubitemid 40070775)
16. Wood JC,. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007; 14: 183-190. (Pubitemid 46597601)
17. Wood JC,. Diagnosis and management of transfusion iron overload: the role of imaging. Am J Hematol 2007; 82 (Suppl 12): 1132-1135. (Pubitemid 350221243)
18. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD,. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465. (Pubitemid 41129616)
19. Vigen KK, Yu H, Francois CJ, Shimakawa A, Reeder SB,. Feasibility of T2* estimation with chemical shift-based water-fat separated cardiac imaging. Proceedings 18th Scientific Meeting, Int Soc Magn Reson Med 2010: 2914.
20. Ramazzotti A, Pepe A, Positano V, Rossi G, De Marchi D, Brizi MG, Luciani A, Midiri M, Sallustio G, Valeri G, Caruso V, Centra M, Cianciulli P, De Sanctis V, Maggio A, Lombardi M,. Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 2009; 30: 62-68.
21. Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beatty PJ, Pineda AR, Brittain JH, Reeder SB,. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007; 26: 1153-1161. (Pubitemid 47548182)
22. Reeder SB, Wen Z, Yu H, Pineda AR, Gold GE, Markl M, Pelc NJ,. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med 2004; 51: 35-45. (Pubitemid 38095700)
23. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB,. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008; 60: 1122-1134.
24. Stanley D, Fidler J, Polzin J, Hwang K,. Multi-echo R2* technique in the quantification of hepatic iron. 12th Scientific Meeting of the International Society for Magnetic Resonance in Medicine. Kyoto, Japan 2004. p 188.
25. Positano V, Salani B, Pepe A, Santarelli MF, De Marchi D, Ramazzotti A, Favilli B, Cracolici E, Midiri M, Cianciulli P, Lombardi M, Landini L,. Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging 2009; 27: 188-197.
26. Wang K, Yu H, Brittain JH, Reeder SB, Du J,. k-space water-fat decomposition with T2* estimation and multifrequency fat spectrum modeling for ultrashort echo time imaging. J Magn Reson Imaging 2010; 31: 1027-1034.
27. He T, Gatehouse PD, Kirk P, Mohiaddin RH, Pennell DJ, Firmin DN,. Myocardial T*2 measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. Magn Reson Med 2008; 60: 350-356.
28. Taouli B, Ehman RL, Reeder SB,. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009; 193: 14-27.
29. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH,. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395. (Pubitemid 39657013)
30. Nobili V, Alisi A, Raponi M,. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15: 6017-6022.
31. Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M,. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 2004; 39: 179-187. (Pubitemid 38461480)
32. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW,. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318. (Pubitemid 28093538)